García-Guerrero J, Herrero A, Bedia M, Araújo R, Castellano JC. Resistencias primarias de VIH en una población penitenciaria. Estudio REPRICOVA-2.
Enferm Infecc Microbiol Clin 2004;
22:29-31. [PMID:
14757005 DOI:
10.1016/s0213-005x(04)73027-x]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
INTRODUCTION
Currently, there are few reports on primary human immunodeficiency virus (HIV) drug resistance in the prison population.
METHODS
This is a descriptive, one-day prevalence study to identify HIV drug-resistant mutations in chronically infected treatment-naïve prisoners. Systematic randomized sampling was performed and genotyping was done by automatic sequencing.
RESULTS
A total of 90 patients were studied. Two samples were found to have nucleoside reverse transcriptase inhibitor (NRTI)-resistant mutations, four had non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant mutations and one had protease inhibitor (PI)-resistant mutations.
CONCLUSIONS
There was a low rate of primary resistance in our series. Therefore, resistance testing is not required before prescribing initial antiretroviral therapy in these patients.
Collapse